These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31612847)

  • 21. Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study.
    Gurnani T; Khurshid KA
    Asian J Psychiatr; 2017 Oct; 29():112-113. PubMed ID: 29061405
    [No Abstract]   [Full Text] [Related]  

  • 22. Ketamine and electroconvulsive therapy: so happy together?
    Cobb K; Nanda M
    Curr Opin Anaesthesiol; 2018 Aug; 31(4):459-462. PubMed ID: 29794567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ketamine's antidepressant effect: literature review on clinical use].
    De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
    Encephale; 2014 Feb; 40(1):15-23. PubMed ID: 24434008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Objective and Subjective Cognitive Function in Patients With Treatment-Resistant Depression Undergoing Repeated Ketamine Infusions.
    Phillips JL; Van Geel A; Burhunduli P; Vasudev D; Batten LA; Norris S; Talbot J; Ortiz A; Owoeye O; Blier P
    Int J Neuropsychopharmacol; 2022 Dec; 25(12):992-1002. PubMed ID: 35931041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remission of treatment-resistant depression with electroconvulsive therapy and ketamine.
    Niemegeers P; Schrijvers D; Madani Y; Sabbe BG
    J ECT; 2014 Sep; 30(3):e31-2. PubMed ID: 24625710
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous ketamine for treatment-resistant major depressive disorder.
    Covvey JR; Crawford AN; Lowe DK
    Ann Pharmacother; 2012 Jan; 46(1):117-23. PubMed ID: 22190250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Repeated Intravenous Ketamine in Treatment-Resistant Geriatric Depression: A Case Series.
    Bryant KA; Altinay M; Finnegan N; Cromer K; Dale RM
    J Clin Psychopharmacol; 2019; 39(2):158-161. PubMed ID: 30742589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
    J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disentangling the association of depression on the anti-fatigue effects of ketamine.
    Saligan LN; Farmer C; Ballard ED; Kadriu B; Zarate CA
    J Affect Disord; 2019 Feb; 244():42-45. PubMed ID: 30312839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    J Psychopharmacol; 2018 Oct; 32(10):1118-1126. PubMed ID: 30260273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Ketamine in Elderly Patients with Treatment-Resistant Depression.
    Medeiros da Frota Ribeiro C; Riva-Posse P
    Curr Psychiatry Rep; 2017 Nov; 19(12):107. PubMed ID: 29138992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.
    Bobo WV; Vande Voort JL; Croarkin PE; Leung JG; Tye SJ; Frye MA
    Depress Anxiety; 2016 Aug; 33(8):698-710. PubMed ID: 27062450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketamine safety and tolerability in clinical trials for treatment-resistant depression.
    Wan LB; Levitch CF; Perez AM; Brallier JW; Iosifescu DV; Chang LC; Foulkes A; Mathew SJ; Charney DS; Murrough JW
    J Clin Psychiatry; 2015 Mar; 76(3):247-52. PubMed ID: 25271445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression.
    Szymkowicz SM; Finnegan N; Dale RM
    J Affect Disord; 2013 May; 147(1-3):416-20. PubMed ID: 23182590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: a case report.
    Zigman D; Blier P
    J Clin Psychopharmacol; 2013 Apr; 33(2):270-2. PubMed ID: 23422387
    [No Abstract]   [Full Text] [Related]  

  • 36. Side-effects associated with ketamine use in depression: a systematic review.
    Short B; Fong J; Galvez V; Shelker W; Loo CK
    Lancet Psychiatry; 2018 Jan; 5(1):65-78. PubMed ID: 28757132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study.
    Nugent AC; Wills KE; Gilbert JR; Zarate CA
    Psychiatry Res Neuroimaging; 2019 Jan; 283():64-66. PubMed ID: 30551012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuation phase intravenous ketamine in adults with treatment-resistant depression.
    Vande Voort JL; Morgan RJ; Kung S; Rasmussen KG; Rico J; Palmer BA; Schak KM; Tye SJ; Ritter MJ; Frye MA; Bobo WV
    J Affect Disord; 2016 Dec; 206():300-304. PubMed ID: 27656788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression.
    Shiroma PR; Johns B; Kuskowski M; Wels J; Thuras P; Albott CS; Lim KO
    J Affect Disord; 2014 Feb; 155():123-9. PubMed ID: 24268616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketamine as an alternative treatment for treatment-resistant depression.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.